Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.29 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | 6 Parkinson's trials, 0 stopped | 1.00 |
| literature PubMed | 51 Parkinson's papers of 13,873 | 0.48 |
| pathways Reactome | in no curated pathway | 0.00 |
No case: the score is under the bar. Receipt 1344
Sealed predictions
- ERG in dopamine neurons, braak+0.05 (p 0.907) → +0.11 (p 0.785)receipt 1351
Swarm cases
receipt 1351: ERG in dopamine neurons, braak
- power
- full sample +0.08 (p 0.741, n 18), 95% CI -0.40 to +0.53. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.11 (p 0.677, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.12 (p 0.633, n 18). could be the mix.
- skeptic
- leave-one-out range -0.01 to +0.21, sign flips 2; without severely affected donors +0.08 (p 0.741, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ERG in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts